Entity Central Index Key
Interest bearing loans and borrowings.
Cover [Abstract]
Document Information [Table]
Document Information [Table]
Classes of share capital [axis]
Classes Of Share Capital [Axis]
Share capital [member]
Classes Of Share Capital [Member]
American Depositary Shares, each Representing one ordinary share.
American Depositary Shares, each Representing one ordinary share
American Depositary Shares Each Representing One Ordinary Share [Member]
Ordinary shares, no par value, with national amount attributable to each ordinary share of €1.
Ordinary shares, no par value, with national amount attributable to each ordinary share of €1
Ordinary Shares No Par Value With National Amount Attributable To Each Ordinary Share Of One [Member]
Entity Addresses, Address Type
Entity Addresses Address Type [Axis]
Address Type
Address Type [Domain]
Business Contact
Business Contact [Member]
Document Information [Line Items]
Document Information [Line Items]
Document Type
Document Type
Amendment Flag
Amendment Flag
Document Period End Date
Document Period End Date
Document Fiscal Year Focus
Document Fiscal Year Focus
Current Fiscal Year End Date
Current Fiscal Year End Date
Document Fiscal Period Focus
Document Fiscal Period Focus
Entity Registrant Name
Entity Registrant Name
Entity Central Index Key
Document Annual Report
Document Annual Report
Document Transition Report
Document Transition Report
Document Registration Statement
Document Registration Statement
Document Shell Company Report
Document Shell Company Report
Entity Current Reporting Status
Entity Current Reporting Status
Entity Voluntary Filers
Entity Voluntary Filers
Entity Interactive Data Current
Entity Interactive Data Current
Entity Filer Category
Entity Filer Category
Entity Well-known Seasoned Issuer
Entity Well Known Seasoned Issuer
Entity Common Stock, Shares Outstanding
Entity Common Stock Shares Outstanding
Entity Shell Company
Entity Shell Company
Entity Emerging Growth Company
Entity Emerging Growth Company
Entity Ex Transition Period
Entity Ex Transition Period
Trading Symbol
Trading Symbol
Title of 12(b) Security
Security12b Title
Security Exchange Name
Security Exchange Name
No Trading Symbol Flag
No Trading Symbol Flag
Entity Incorporation, State or Country Code
Entity Incorporation State Country Code
Entity File Number
Entity File Number
Contact Personnel Name
Contact Personnel Name
Entity Address, Address Line One
Entity Address Address Line1
Entity Address, City or Town
Entity Address City Or Town
Entity Address, Country
Entity Address Country
Entity Address, Postal Zip Code
Entity Address Postal Zip Code
City Area Code
City Area Code
Local Phone Number
Local Phone Number
Contact Personnel Email Address
Contact Personnel Email Address
Document Accounting Standard
Document Accounting Standard
Deferred expense current.
Statement Of Financial Position [Abstract]
Assets
Assets [Abstract]
Non-current assets
Noncurrent Assets [Abstract]
Intangible assets
Intangible Assets And Goodwill
Property, plant and equipment
Property Plant And Equipment
Right-of-use assets
Rightofuse Assets
Other financial assets
Other Noncurrent Financial Assets
Total non-current assets
Noncurrent Assets
Current assets
Current Assets [Abstract]
Inventories
Inventories
Trade receivables
Current Trade Receivables
Other financial assets
Other Current Financial Assets
Other assets
Other Current Assets
Income tax assets
Current Tax Assets Current
Deferred expense
Deferred Expense Current
Cash and cash equivalents
Cash And Cash Equivalents
Total current assets
Current Assets
Total assets
Assets
Equity and liabilities
Equity And Liabilities [Abstract]
Equity
Equity [Abstract]
Share capital
Issued Capital
Capital reserve
Capital Reserve
Treasury shares
Treasury Shares
Accumulated losses
Accumulated Other Comprehensive Income
Other reserves
Other Reserves
Equity attributable to equity holders of the parent
Equity Attributable To Owners Of Parent
Non-controlling interest
Noncontrolling Interests
Total equity
Equity
Non-current liabilities
Noncurrent Liabilities [Abstract]
Financial liabilities
Noncurrent Financial Liabilities
Contract liabilities
Noncurrent Contract Liabilities
Total non-current liabilities
Noncurrent Liabilities
Current liabilities
Current Liabilities [Abstract]
Tax provisions
Current Tax Liabilities Current
Provisions
Current Provisions
Financial liabilities
Current Financial Liabilities
Trade payables
Trade And Other Current Payables To Trade Suppliers
Contract liabilities
Current Contract Liabilities
Other financial liabilities
Other Current Financial Liabilities
Other liabilities
Other Current Liabilities
Total current liabilities
Current Liabilities
Total liabilities
Liabilities
Total equity and liabilities
Equity And Liabilities
Stock split conversion ratio.
Stock split ratio
Stock Split Conversion Ratio
Profit Loss [Abstract]
Revenues from contracts with customers
Revenue From Contracts With Customers
Cost of sales
Cost Of Sales
Gross profit
Gross Profit
Research and development expenses
Research And Development Expense
Sales and marketing expenses
Sales And Marketing Expense
General and administrative expenses
General And Administrative Expense
Other operating income
Miscellaneous Other Operating Income
Other operating expenses
Miscellaneous Other Operating Expense
Operating loss
Profit Loss From Operating Activities
Finance income
Finance Income
Finance expenses
Finance Costs
Interest expense related to lease liability
Interest Expense On Lease Liabilities
Share of loss of equity method investees
Share Of Profit Loss Of Associates And Joint Ventures Accounted For Using Equity Method
Loss before tax
Profit Loss Before Tax
Income taxes
Income Tax Expense Continuing Operations
Loss for the period
Profit Loss
Attributable to:
Profit Loss Attributable To [Abstract]
Equity holders of the parent
Profit Loss Attributable To Owners Of Parent
Non-controlling interests
Profit Loss Attributable To Noncontrolling Interests
Earnings per share
Earnings Per Share [Abstract]
Basic & diluted, loss per share for the year attributable to ordinary equity holders of the parent
Basic And Diluted Earnings Loss Per Share
Statement Of Comprehensive Income [Abstract]
Loss for the period
Other comprehensive income
Other Comprehensive Income [Abstract]
Other comprehensive income that may be reclassified to profit or loss in subsequent periods (net of tax)
Components Of Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Net Of Tax [Abstract]
Exchange differences on translation of foreign operations
Other Comprehensive Income Net Of Tax Exchange Differences On Translation
Net other comprehensive income that may be reclassified to profit or loss in subsequent periods
Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Net Of Tax
Other comprehensive income for the period, net of tax
Other Comprehensive Income
Comprehensive loss for the period, net of tax
Comprehensive Income
Attributable to:
Comprehensive Income Attributable To [Abstract]
Equity holders of the parent
Comprehensive Income Attributable To Owners Of Parent
Non- controlling interests
Comprehensive Income Attributable To Noncontrolling Interests
Increase decrease through initial public offering.
Increase decrease through acquisition of noncontrolling interests.
Recognition of costs related to equity transactions.
Increase (decrease) through settlement of sharebased payment plan.
Statement Of Changes In Equity [Abstract]
Statement Of Changes In Equity [Table]
Statement Of Changes In Equity [Table]
Components of equity [axis]
Components Of Equity [Axis]
Equity [member]
Equity [Member]
Share Capital
Issued Capital [Member]
Capital Reserve
Capital Reserve [Member]
Treasury Shares
Treasury Shares [Member]
Accumulated Losses
Accumulated Other Comprehensive Income [Member]
Other Reserves
Other Reserves [Member]
Foreign currency translation reserve.
Foreign Currency Translation Reserve
Foreign Currency Translation Reserve [Member]
Total
Equity Attributable To Owners Of Parent [Member]
Non-controlling Interest
Noncontrolling Interests [Member]
Capital increase series B.
Series B
Capital Increase Series B [Member]
Statement Of Changes In Equity [Line Items]
Statement Of Changes In Equity [Line Items]
Beginning balance
Other comprehensive income
Total comprehensive income
Issuance of share capital
Issue Of Equity
Capital increase initial public offering (referred to as IPO)
Increase Decrease Through Initial Public Offering
Acquisition of non-controlling interest
Increase Decrease Through Acquisition Of Noncontrolling Interests
Transaction costs
Recognition Of Costs Related To Equity Transactions
Share-based payments
Increase Decrease Through Sharebased Payment Transactions
Settlement of share-based payment plan
Increase Decrease Through Settlement Of Sharebased Payment Plan
Ending balance
Adjustments for interest on lease liability.
Adjustments for increase decrease in trade account receivable and contract assets.
Adjustments for increase decrease in trade and other payables contract liabilities and provisions..
Working capital adjustments abstract.
Statement Of Cash Flows [Abstract]
Operating activities
Cash Flows From Used In Operating Activities [Abstract]
Loss for the period
Income taxes
Adjustments to reconcile loss before tax to net cash flows:
Adjustments For Reconcile Profit Loss [Abstract]
Depreciation and amortization of property, plant, equipment and intangible assets
Adjustments For Depreciation And Amortisation Expense
Share-based payment expense
Adjustments For Sharebased Payments
Net foreign exchange differences
Adjustments For Unrealised Foreign Exchange Losses Gains
(Gain)/Loss on disposal of property, plant and equipment
Adjustments For Gain Loss On Disposals Property Plant And Equipment
Finance income
Adjustments For Finance Income
Interest on lease liability
Adjustments For Interest On Lease Liability
Finance expense
Adjustments For Finance Costs
Share of loss of an associate and a joint venture
Working capital adjustments:
Working Capital Adjustments [Abstract]
Decrease/(Increase) in trade receivable and contract assets
Adjustments For Increase Decrease In Trade Account Receivable And Contract Assets
Decrease/(Increase) in inventories
Adjustments For Decrease Increase In Inventories
(Decrease)/Increase in trade and other payables, contract liabilities and provisions
Adjustments For Increase Decrease In Trade And Other Payables Contract Liabilities And Provisions
Interest received
Interest Received Classified As Operating Activities
Interest paid
Interest Paid Classified As Operating Activities
Income tax received (paid), net
Income Taxes Paid Refund Classified As Operating Activities
Net cash flows used in operating activities
Cash Flows From Used In Operating Activities
Investing activities
Cash Flows From Used In Investing Activities [Abstract]
Purchase of property, plant and equipment
Purchase Of Property Plant And Equipment Classified As Investing Activities
Proceeds from sale of property, plant and equipment
Proceeds From Sales Of Property Plant And Equipment Classified As Investing Activities
Purchase of intangibles assets
Purchase Of Intangible Assets Classified As Investing Activities
Acquisition of subsidiaries and businesses, net of cash acquired
Cash Flows Used In Obtaining Control Of Subsidiaries Or Other Businesses Classified As Investing Activities
Net cash flows used in investing activities
Cash Flows From Used In Investing Activities
Financing activities
Cash Flows From Used In Financing Activities [Abstract]
Proceeds from issuance of share capital, net of costs
Proceeds From Issuing Shares
Proceeds from loans and borrowings
Proceeds From Borrowings Classified As Financing Activities
Payment of finance lease liabilities
Payments Of Lease Liabilities Classified As Financing Activities
Net cash flows from/(used in) financing activities
Cash Flows From Used In Financing Activities
Net increase/(decrease) in cash and cash equivalents
Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes
Change in cash resulting from exchange rate differences
Effect Of Exchange Rate Changes On Cash And Cash Equivalents
Cash and cash equivalents at January 1
Cash and cash equivalents at December 31
Disclosure of corporate information explanatory.
Disclosure of corporate information explanatory.
Disclosure Of Corporate Information Explanatory [Abstract]
Corporate information
Disclosure Of Corporate Information Explanatory
Disclosure of summary of significant accounting policies abstract.
Disclosure Of Summary Of Significant Accounting Policies [Abstract]
Significant Accounting Policies
Disclosure Of Summary Of Significant Accounting Policies Explanatory
Disclosure of accounting judgements and estimates.
Disclosure Of Accounting Judgements And Estimates [Abstract]
Significant Accounting Judgments, Estimates and Assumptions Continued
Disclosure Of Accounting Judgements And Estimates Explanatory
Disclosure of revenue from contracts with customers.
Disclosure Of Revenue From Contracts With Customers [Abstract]
Revenue from contracts with customers
Disclosure Of Revenue From Contracts With Customers Explanatory
Disclosure Of Significant Investments In Subsidiaries [Abstract]
Group information
Disclosure Of Composition Of Group Explanatory
Disclosure Of Business Combinations [Abstract]
Business Combinations
Disclosure Of Business Combinations Explanatory
The detailed information about income and expenses.
Analysis Of Income And Expense [Abstract]
Income and Expenses
Disclosure Of Income And Expenses Explanatory
Major Components Of Tax Expense Income [Abstract]
Income Tax
Disclosure Of Income Tax Explanatory
Earnings per share
Disclosure Of Earnings Per Share Explanatory
Disclosure Of Property Plant And Equipment [Abstract]
Property, Plant and Equipment
Disclosure Of Property Plant And Equipment Explanatory
Disclosure Of Intangible Assets [Abstract]
Intangible Assets
Disclosure Of Intangible Assets Explanatory
Disclosure Of Financial Instruments [Abstract]
Financial Assets and Financial Liabilities
Disclosure Of Offsetting Of Financial Assets And Financial Liabilities Explanatory
Classes Of Inventories [Abstract]
Inventories
Disclosure Of Inventories Explanatory
Trade And Other Receivables [Abstract]
Trade Receivables
Disclosure Of Trade And Other Receivables Explanatory
Miscellaneous Current Assets [Abstract]
Other Assets
Disclosure Of Other Current Assets Explanatory
Disclosure Of Classes Of Share Capital [Abstract]
Issued Capital and Reserves
Disclosure Of Share Capital Reserves And Other Equity Interest Explanatory
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Abstract]
Share-based payments
Disclosure Of Sharebased Payment Arrangements Explanatory
Miscellaneous Current Liabilities [Abstract]
Other Liabilities
Disclosure Of Other Liabilities Explanatory
Presentation Of Leases For Lessee [Abstract]
Leases
Disclosure Of Leases Explanatory
Disclosure Of Operating Segments [Abstract]
Segment Information
Disclosure Of Entitys Reportable Segments Explanatory
Disclosure Of Transactions Between Related Parties [Abstract]
Related Party Disclosures
Disclosure Of Related Party Explanatory
Disclosure of events after reporting period.
Disclosure Of Events After Reporting Period [Abstract]
Events After the Reporting Period
Disclosure Of Events After Reporting Period Explanatory
Basis of Preparation
Disclosure Of Basis Of Preparation Of Financial Statements Explanatory
Basis of Consolidation
Disclosure Of Basis Of Consolidation Explanatory
Business combinations and Goodwill
Description Of Accounting Policy For Business Combinations And Goodwill Explanatory
Description of accounting policy for assets and liabilities explanatory.
Current versus Non-Current Classifications
Description Of Accounting Policy For Assets And Liabilities Explanatory
Fair Value Measurement
Description Of Accounting Policy For Fair Value Measurement Explanatory
Description of accounting policy for revenue from contracts with customers explanatory.
Revenue from Contracts with Customers
Description Of Accounting Policy For Revenue From Contracts With Customers Explanatory
Government Grants
Description Of Accounting Policy For Government Grants
Taxes
Description Of Accounting Policy For Income Tax Explanatory
Foreign Currencies
Description Of Accounting Policy For Foreign Currency Translation Explanatory
Property, Plant and Equipment
Description Of Accounting Policy For Property Plant And Equipment Explanatory
Leases
Description Of Accounting Policy For Leases Explanatory
Intangible Assets
Description Of Accounting Policy For Intangible Assets And Goodwill Explanatory
Financial Instruments – Initial Recognition and Subsequent Measurement
Description Of Accounting Policy For Financial Instruments Explanatory
Inventories
Description Of Accounting Policy For Measuring Inventories
Impairment of Non-Financial Assets
Description Of Accounting Policy For Impairment Of Nonfinancial Assets Explanatory
Cash and Cash Equivalents
Description Of Accounting Policy To Determine Components Of Cash And Cash Equivalents
Provisions
Description Of Accounting Policy For Provisions Explanatory
Share-Based Payments
Description Of Accounting Policy For Sharebased Payment Transactions Explanatory
Description of accounting policy for initial application of standards explanatory.
Standards applied for the First Time
Description Of Accounting Policy For Initial Application Of Standards Explanatory
Description of accounting policy for standard issued but not yet effective explanatory.
Standard issued but not yet effective
Description Of Accounting Policy For Standard Issued But Not Yet Effective Explanatory
Disclosure of property plant and equipment estimated useful lives explanatory.
Useful Lives Applied to the Group's Property, Plant and Equipment
Disclosure Of Property Plant And Equipment Estimated Useful Lives Explanatory
Disclosure of right of use assets estimated useful lives explanatory.
Useful Lives Applied to the Group's Right-of-use Assets
Disclosure Of Right Of Use Assets Estimated Useful Lives Explanatory
Disclosure of intangible assets useful life explanatory.
Useful Lives Applied to the Group's Intangible Assets
Disclosure Of Intangible Assets Useful Life Explanatory
Summary of Disaggregation of Revenue from Contracts with Customers
Disclosure Of Disaggregation Of Revenue From Contracts With Customers Explanatory
Disclosure of transactions resulting from product sales included within revenue from other sales transactions explanatory.
Summary of Transactions Resulting from Product Sales Included within Revenue from Other Sales Transactions
Disclosure Of Transactions Resulting From Product Sales Included Within Revenue From Other Sales Transactions Explanatory
Disclosure of contract balances from contracts with customers explanatory.
Summary of Contract Balances
Disclosure Of Contract Balances From Contracts With Customers Explanatory
Revenue recognized in the reporting period, which has been included in contract liabilities at the beginning of the year.
Revenue Recognized from Payments of Past Periods
Disclosure Of Recognition Of Revenue Explanatory
Summary of Deferred Revenue Allocated to Remaining Performance Obligations (Unsatisfied or Partially Unsatisfied)
Disclosure Of Performance Obligations Explanatory
Summary of Information about Subsidiaries
Disclosure Of Significant Investments In Subsidiaries Explanatory
Disclosure of significant investments by parent company.
Summary of Information about Parent Company
Disclosure Of Significant Investments By Parent Company Explanatory
Disclosure of entity with significant influence over the group.
Summary of Information about Entity with Significant Influence Over Group
Disclosure Of Entity With Significant Influence Over Group Explanatory
Summary of Fair Values of Identifiable Net Assets of MAB Discovery
Disclosure Of Detailed Information About Business Combinations Explanatory
Cost of Sales
Disclosure Of Cost Of Sales Explanatory
Research and Development Expenses
Disclosure Of Research And Development Expense Explanatory
Disclosure of sales and marketing expenses.
Sales and Marketing Expenses
Disclosure Of Sales And Marketing Expenses Explanatory
General and Administrative Expenses
Disclosure Of General And Administrative Expense Explanatory
Other Operating Income
Disclosure Of Other Operating Income Explanatory
Finance Income
Disclosure Of Finance Income Explanatory
Finance Expenses
Disclosure Of Finance Cost Explanatory
Disclosure of reconciliation of tax expense to estimated tax rate.
Summary of Reconciliation of Tax Expense to Estimated Tax Rate
Disclosure Of Reconciliation Of Tax Expense To Estimated Tax Rate Explanatory
Summary of Deferred Taxes
Disclosure Of Temporary Difference Unused Tax Losses And Unused Tax Credits Explanatory
Disclosure of accumulated tax losses.
Summary of Accumulated Tax Losses
Disclosure Of Accumulated Tax Losses Explanatory
Summary of Income and Share Data Used in the Basic and Diluted EPS Calculations
Earnings Per Share Explanatory
Summary of Property Plant and Equipment
Disclosure Of Detailed Information About Property Plant And Equipment Explanatory
Summary of Detailed Information About Intangible Assets
Disclosure Of Detailed Information About Intangible Assets Explanatory
Disclosure of goodwill acquired in respective business combinations.
Summary of Goodwill Recognized
Disclosure Of Goodwill Acquired In Respective Business Combinations Explanatory
Summary of Cash and Cash Equivalents
Disclosure Of Cash And Cash Equivalents Explanatory
Summary of Financial Assets at Amortized Cost
Disclosure Of Financial Assets Explanatory
Disclosure of financial liabilities interest-bearing loans and borrowings.
Summary of Financial Liabilities at Amortized Cost
Disclosure Of Financial Liabilities Interest Bearing Loans And Borrowings Explanatory
Disclosure of foreign currency risk.
Summary of Carrying Amount of Monetary Assets
Disclosure Of Foreign Currency Risk Explanatory
Summary of Effect of Changes in Foreign Exchange Rates
Disclosure Of Effect Of Changes In Foreign Exchange Rates Explanatory
Summary of Maturity Profile of Financial Liabilities Based on Contractual Undiscounted Payments
Disclosure Of Financial Liabilities Explanatory
Summary of Changes in Liabilities Arising From Financing Activities
Disclosure Of Reconciliation Of Liabilities Arising From Financing Activities Explanatory
Disclosure of classes of inventories.
Summary of Inventories
Disclosure Of Classes Of Inventories Explanatory
Disclosure of detailed information about trade and other receivables explanatory.
Summary of Trade Receivables
Disclosure Of Detailed Information About Trade And Other Receivables Explanatory
Disclosure of detailed information about other assets explanatory.
Summary of Other Assets
Disclosure Of Detailed Information About Other Assets Explanatory
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Table]
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Table]
Types of share-based payment arrangements [axis]
Types Of Sharebased Payment Arrangements [Axis]
Share-based payment arrangements [member]
Sharebased Payment Arrangements [Member]
Chief executive officer grant.
Chief Executive Officer Grant
Chief Executive Officer Grant [Member]
Employee stock ownership plan.
Employee Stock Ownership Plan
Employee Stock Ownership Plan [Member]
Share appreciation right.
Share Appreciation Right
Share Appreciation Right [Member]
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Summary of Inputs Used in Measurement of Fair Value at Grant Date
Disclosure Of Indirect Measurement Of Fair Value Of Goods Or Services Received Share Options Granted During Period Explanatory
Schedule of Number and Weighted-Average Exercise Price of Share Options
Disclosure Of Number And Weighted Average Exercise Prices Of Share Options Explanatory
Schedule of Expense Recognized for Employee Services Received
Explanation Of Effect Of Sharebased Payments On Profit Or Loss
Disclosure of Detailed Information About Other Liabilities Explanatory
Summary of Other Liabilities
Disclosure Of Detailed Information About Other Liabilities Explanatory
Summary of Right-of-Use Assets within Statement of Financial Positions
Disclosure Of Quantitative Information About Rightofuse Assets Explanatory
Disclosure of detailed information about lease liabilities.
Summary of Other Financial Liabilities
Disclosure Of Detailed Information About Lease Liabilities Explanatory
Disclosure of detailed information about lease expense recognized instatement of operations.
Summary of Amounts Recognized in Consolidated Statement of Operations
Disclosure Of Detailed Information About Lease Expense Recognized Instatement Of Operations Explanatory
Reconciliation of Segment Figures to Group Figure
Disclosure Of Operating Segments Explanatory
Summary of Compensation of Key Management Personnel
Disclosure Of Information About Key Management Personnel Explanatory
Summary of Transactions Between Other Related Parties
Disclosure Of Transactions Between Related Parties Explanatory
Payment terms in contracts with customers
Description Of Significant Payment Terms In Contracts With Customers
Disclosure Of Property Plant And Equipment [Table]
Disclosure Of Property Plant And Equipment [Table]
Classes of property, plant and equipment [axis]
Classes Of Property Plant And Equipment [Axis]
Property, plant and equipment [member]
Property Plant And Equipment [Member]
Buildings
Buildings [Member]
Equipment, tools and installations.
Equipment, Tools and Installations
Equipment Tools And Installations [Member]
Statistical Measurement
Range [Axis]
Statistical Measurement
Range [Member]
Minimum
Bottom Of Range [Member]
Maximum
Top Of Range [Member]
Disclosure Of Property Plant And Equipment [Line Items]
Disclosure Of Property Plant And Equipment [Line Items]
Property, plant and equipment, Useful life (Years)
Useful Life Measured As Period Of Time Property Plant And Equipment
Useful life measured as period of time right-of-use-assets.
Disclosure Of Quantitative Information About Leases For Lessee [Abstract]
Disclosure Of Quantitative Information About Rightofuse Assets [Table]
Disclosure Of Quantitative Information About Rightofuse Assets [Table]
Classes of assets [axis]
Classes Of Assets [Axis]
Assets [member]
Classes Of Assets [Member]
Automobiles
Vehicles [Member]
Disclosure Of Quantitative Information About Rightofuse Assets [Line Items]
Disclosure Of Quantitative Information About Rightofuse Assets [Line Items]
Right-of-use assets, Useful life (Years)
Useful Life Measured As Period Of Time Right Of Use Assets
Disclosure Of Intangible Assets [Table]
Disclosure Of Intangible Assets [Table]
Classes of intangible assets other than goodwill [axis]
Classes Of Intangible Assets Other Than Goodwill [Axis]
Intangible assets other than goodwill [member]
Intangible Assets Other Than Goodwill [Member]
Intellectual property rights.
Intellectual Property Rights
Intellectual Property Rights [Member]
Licenses
Licences [Member]
Disclosure Of Intangible Assets [Line Items]
Disclosure Of Intangible Assets [Line Items]
Intangible assets, Useful life (Years)
Useful Life Measured As Period Of Time Intangible Assets Other Than Goodwill
Financial liabilities measured at fair value through profit or loss
Financial Liabilities At Fair Value Through Profit Or Loss
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Abstract]
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Table]
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Table]
Products and services [axis]
Products And Services [Axis]
Products and services [member]
Products And Services [Member]
Collaboration and license agreement.
Collaboration and License Agreement
Collaboration And License Agreement [Member]
Other sales transactions.
Other Sales Transactions
Other Sales Transactions [Member]
Major customers [axis]
Major Customers [Axis]
Customers [member]
Major Customers [Member]
Genentech Inc.
Genentech Inc.
Genentech Inc [Member]
Pfizer Inc.
Pfizer Inc.
Pfizer Inc [Member]
Sanofi S.A.
Sanofi S.A.
Sanofi S A [Member]
Genmab A/S.
Genmab A/S
Genmab A S [Member]
Eli Lilly and Company.
Eli Lilly and Company
Eli Lilly And Company [Member]
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Line Items]
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Line Items]
Payments from contracts with customers received through current reporting period.
Collaboration agreement.
Collaboration Agreement
Collaboration Agreement [Member]
Intangible assets with indefinite useful life [axis]
Intangible Assets With Indefinite Useful Life [Axis]
Intangible assets with indefinite useful life [member]
Intangible Assets With Indefinite Useful Life [Member]
Cellscript sublicense.
Cellscript Sublicense
Cellscript Sublicense [Member]
Bill-and-hold Transaction [Member]
Bill and Hold Transaction
Bill And Hold Transaction [Member]
Payments from customers
Payments From Contracts With Customers Received Through Current Reporting Period
Contract liabilities
Contract Liabilities
Percentage of reimbursement of sublicense costs.
Sublicense agreement date.
Percentage of reimbursement of sublicense costs
Percentage Of Reimbursement Of Sublicense Costs
Sublicense agreement date
Sublicense Agreement Date
Subsidiaries [axis]
Significant Investments In Subsidiaries [Axis]
Entity's total for subsidiaries [member]
Entitys Total For Subsidiaries [Member]
JPT Peptide Technologies GmbH
JPT Peptide Technologies GmbH
J P T Peptide Technologies Gmb H [Member]
Product sales of JPT Peptide Technologies GmbH
Trade receivable maturity period.
Trade receivable maturity period
Trade Receivable Maturity Period
Upfront fees or unconditional right of consideration.
Revenue recognized included in contract liabilities at the beginning of the year.
Upfront fees or unconditional right of consideration from collaboration and license agreements
Upfront Fees Or Unconditional Right Of Consideration
Deferred revenue recognized included in contract liabilities
Deferred Revenue Recognized Included Contract Liabilities
Amounts included in contract liabilities at the beginning of the year
Description of when entity typically satisfies performance obligations
Description Of When Entity Typically Satisfies Performance Obligations
Disclosure Of Performance Obligations [Abstract]
Disclosure Of Performance Obligations [Table]
Disclosure Of Performance Obligations [Table]
Maturity [axis]
Maturity [Axis]
Aggregated time bands [member]
Aggregated Time Bands [Member]
Within One Year
Not Later Than One Year [Member]
More Than One Year
Later Than One Year [Member]
Performance obligations [axis]
Performance Obligations [Axis]
Performance obligations [member]
Performance Obligations [Member]
Unsatisfied or partially unsatisfied.
Unsatisfied Or Partially Unsatisfied
Unsatisfied Or Partially Unsatisfied [Member]
Disclosure Of Performance Obligations [Line Items]
Disclosure Of Performance Obligations [Line Items]
The consideration from contracts with customers is not included in the disclosure of the transaction price allocated to the remaining performance obligations.
Description of deferred revenue allocated to the remaining performance obligations
Explanation Of Whether Any Consideration From Contracts With Customers Is Not Included In Disclosure Of Transaction Price Allocated To Remaining Performance Obligations
Deferred revenue allocated to the remaining performance obligations
Consideration From Contracts With Customers Is Not Included In Disclosure Of Transaction Price Allocated To Remaining Performance Obligations
Disclosure Of Significant Investments In Subsidiaries [Table]
Disclosure Of Significant Investments In Subsidiaries [Table]
BioNTech RNA Pharmaceuticals GmbH.
BioNTech RNA Pharmaceuticals GmbH
Bio N Tech R N A Pharmaceuticals Gmb H [Member]
BioNTech Delivery Technologies GmbH.
BioNTech Delivery Technologies GmbH (previously BioNTech Protein Therapeutics GmbH
Bio N Tech Delivery Technologies Gmb H [Member]
BioNTech Diagnostics GmbH.
BioNTech Diagnostics GmbH
Bio N Tech Diagnostics Gmb H [Member]
BioNTech Small Molecules GmbH.
BioNTech Small Molecules GmbH
Bio N Tech Small Molecules Gmb H [Member]
BioNTech IVAC GmbH.
BioNTech IVAC GmbH (previously BioNTech Business Services GmbH)
Bio N Tech I V A C Gmb H [Member]
BioNTech Austria Beteiligungen GmbH.
BioNTech Austria Beteiligungen GmbH
Bio N Tech Austria Beteiligungen Gmb H [Member]
BioNTech Innovative Manufacturing Services GmbH
BioNTech Innovative Manufacturing Services GmbH
Bio N Tech Innovative Manufacturing Services Gmb H [Member]
reBOOST Management GmbH.
reBOOST Management GmbH
Re B O O S T Management Gmb H [Member]
JPT Inc. (previously TheraCode JPT Inc.).
JPT Inc. (previously TheraCode JPT Inc.)
J P T Inc Previously Thera Code J P T Inc [Member]
BioNTech USA Holding LLC.
BioNTech USA Holding LLC
Bio N Tech U S A Holding L L C [Member]
BioNTech Research and Development Inc.
BioNTech Research and Development Inc.
Bio N Tech Research And Development Inc [Member]
BioNTech Cell & Gene Therapies GmbH.
BioNTech Cell & Gene Therapies GmbH
Bio N Tech Cell And Gene Therapies Gmb H [Member]
BioNTech Real Estate Holding GmbH.
BioNTech Real Estate Holding GmbH (Previously Apta IT GmbH)
Bio N Tech Real Estate Holding Gmb H [Member]
BioNTech Real Estate Verwaltungs GmbH.
BioNTech Real Estate Verwaltungs GmbH
Bio N Tech Real Estate Verwaltungs Gmb H [Member]
BioNTech Real Estate GmbH & Co. KG.
BioNTech Real Estate GmbH & Co. KG
Bio N Tech Real Estate Gmb H And Co K G [Member]
Disclosure Of Significant Investments In Subsidiaries [Line Items]
Disclosure Of Significant Investments In Subsidiaries [Line Items]
Country of incorporation
Country Of Incorporation Or Residence Of Subsidiary
Registered office
Principal Place Of Business Of Subsidiary
% equity interest
Proportion Of Ownership Interest In Subsidiary
Number of new entities.
BioNTech USA Holding, LLC and BioNTech Research & Development, Inc.
BioNTech USA Holding, LLC and BioNTech Research & Development, Inc.
Bio N Tech U S A Holding L L C And Bio N Tech Research And Development Inc [Member]
Categories of related parties [axis]
Categories Of Related Parties [Axis]
Entity's total for related parties [member]
Entitys Total For Related Parties [Member]
Ownership
Ownership [Axis]
Ownership
Ownership [Domain]
AT Impf GmbH, parent company of BioNTech.
AT Impf GmbH
A T Impf Gmb H [Member]
Counterparty Name
Counterparty Name [Axis]
Counterparty Name
Repurchase Agreement Counterparty Name [Domain]
ATHOSKG.
ATHOS KG
A T H O S K G [Member]
Number of entities
Number Of New Entities
BioNTech.
BioNTech
Bio N Tech [Member]
Ownership of ordinary shares in BioNTech
Medine GmbH.
Medine GmbH
Medine Gmb H [Member]
Disclosure Of Business Combinations [Table]
Disclosure Of Business Combinations [Table]
Business combinations [axis]
Business Combinations [Axis]
Entity's total for business combinations [member]
Entitys Total For Business Combinations [Member]
MAB Discovery GmbH.
MAB Discovery GmbH
M A B Discovery Gmb H [Member]
Segments [axis]
Segments [Axis]
Segments [member]
Segments [Member]
Technology platform business segment.
Technology Platform Business Segment
Technology Platform Business Segment [Member]
Scenario
Statement Scenario [Axis]
Scenario
Scenario Unspecified [Domain]
ProForma
Pro Forma [Member]
Disclosure Of Business Combinations [Line Items]
Disclosure Of Business Combinations [Line Items]
Name of acquiree
Name Of Acquiree
Total consideration
Acquisitiondate Fair Value Of Total Consideration Transferred
Date of acquisition
Date Of Acquisition2013
Net cash acquired.
Payments to acquire business.
Assets
Acquisitiondate Fair Value Of Total Consideration Transferred [Abstract]
Goodwill
Goodwill Recognised As Of Acquisition Date
Other intangible assets
Other Tangible Or Intangible Assets Transferred
Property, plant and equipment
Property Plant And Equipment Recognised As Of Acquisition Date
Inventories
Inventory Recognised As Of Acquisition Date
Total identifiable net assets at fair value
Net cash acquired
Net Cash Acquired
Cash paid
Payments To Acquire Business
Net cash flow on acquisition
Loss before tax
Revenues
Transaction costs
Acquisitionrelated Costs Recognised As Expense For Transaction Recognised Separately From Acquisition Of Assets And Assumption Of Liabilities In Business Combination
Cash consideration
Cash Transferred
Assumption of liabilities
Liabilities Incurred
Line items representing income and expenses.
Schedule of Income and expenses.
Disclosure Of Income And Expenses [Table]
Disclosure Of Income And Expenses [Table]
Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]
Carrying Amount Accumulated Depreciation Amortisation And Impairment And Gross Carrying Amount [Axis]
Carrying amount [member]
Carrying Amount [Member]
Depreciation and Amortization
Accumulated Depreciation And Amortisation [Member]
Axis representing income and expenses by nature.
Income And Expenses By Nature
Income And Expenses By Nature [Axis]
Income and expense by nature.
Income And Expenses By Nature Member
Income And Expenses By Nature [Member]
Wages, benefits and social security expense.
Wages, Benefits and Social Security Expense
Wages Benefits And Social Security Expense [Member]
Laboratory supplies.
Laboratory Supplies
Laboratory Supplies [Member]
Purchased Services.
Purchased Services
Purchased Services [Member]
Other income expense.
Other
Other Income Expense [Member]
Disclosure Of Income And Expenses [Line Items]
Disclosure Of Income And Expenses [Line Items]
Costs of sales
Lease and lease related cost.
Lease and Lease Related Cost
Lease And Lease Related Cost [Member]
IT costs.
IT Costs
I T Costs [Member]
Travel costs.
Travel Costs
Travel Costs [Member]
Transport costs.
Transport Costs
Transport Costs [Member]
Job advertisement expenses.
Job Advertisement Expenses
Job Advertisement Expenses [Member]
Research and development expenses
Sales and marketing expenses
IT and Office Equipment
Office Equipment [Member]
Insurance premiums.
Insurance Premiums
Insurance Premiums [Member]
General and administrative expenses
Government grant.
Government Grants
Government Grants [Member]
Interest income
Revenue From Interest
Foreign exchange gains (net)
Net Foreign Exchange Gain
Total
Financial instruments measured at amortized cost
Financial Instruments Measured At Amortised Cost
Foreign exchange loss (net)
Net Foreign Exchange Loss
Total
Disclosure Of Temporary Difference Unused Tax Losses And Unused Tax Credits [Abstract]
Property tax expense
Property Tax Expense
Government grants exempted from taxes.
Add back for trade tax purposes.
Non recognition of tax effect on share based payment expenses.
Tax effective equity transaction costs.
Tax effect of nonrecognition of deferred taxes on tax losses and temporary differences.
Tax effect in deviation valuation allowance from change in tax rate.
Income tax expense excluding property tax.
Loss before tax
Expected tax benefit (based on BioNTech`s statutory tax rate of 30.78%, 2018: 30.99%, 2017: 30.86%)
Tax Expense Income At Applicable Tax Rate
Effects
Reconciliation Of Accounting Profit Multiplied By Applicable Tax Rates [Abstract]
Government grants exempted from taxes
Government Grants Exempted From Taxes
Non-deductible expenses
Tax Effect Of Expense Not Deductible In Determining Taxable Profit Tax Loss
Add-back for trade tax purposes
Add Back For Trade Tax Purposes
Non-recognition of tax-effect on share-based payment expenses
Non Recognition Of Tax Effect On Share Based Payment Expenses
Tax-effective equity transaction costs
Tax Effective Equity Transaction Costs
Utilization of tax losses
Tax Effect Of Tax Losses
Non-recognition of deferred taxes on tax losses and temporary differences
Tax Effect Of Nonrecognition Of Deferred Taxes On Tax Losses And Temporary Differences
Deviation valuation allowance prior year due to change tax rate
Tax Effect In Deviation Valuation Allowance From Change In Tax Rate
Effect from lower foreign income tax rate
Tax Effect Of Foreign Tax Rates
Adjustment prior year tax
Adjustments For Current Tax Of Prior Period
Other effects
Other Tax Effects For Reconciliation Between Accounting Profit And Tax Expense Income
Income tax expense
Government grants exempted from taxes
Tax Effect Of Revenues Exempt From Taxation2011
Deviation valuation allowance prior year due to change tax rate
Tax Effect From Change In Tax Rate
Adjustment prior year tax
Adjustments For Deferred Tax Of Prior Periods
Income tax expense excluding property tax
Income Tax Expense Excluding Property Tax
Statutory tax rate
Applicable Tax Rate
Net Deferred Tax Assets And Liabilities [Abstract]
Disclosure Of Temporary Difference Unused Tax Losses And Unused Tax Credits [Table]
Disclosure Of Temporary Difference Unused Tax Losses And Unused Tax Credits [Table]
Gross Carrying Amount
Gross Carrying Amount [Member]
Valuation adjustment.
Valuation Adjustment
Valuation Adjustment [Member]
Temporary difference, unused tax losses and unused tax credits [axis]
Temporary Difference Unused Tax Losses And Unused Tax Credits [Axis]
Temporary difference, unused tax losses and unused tax credits [member]
Temporary Difference Unused Tax Losses And Unused Tax Credits [Member]
Fixed assets.
Fixed assets
Fixed Assets [Member]
Leases.
Leases
Leases [Member]
Inventory.
Inventories
Inventory [Member]
Contract liabilities.
Contract liabilities (prior year revenues)
Contract Liabilities [Member]
Provisions.
Provisions
Provisions [Member]
Other deferred taxes.
Other (incl. deferred expenses)
Other Deferred Taxes [Member]
Disclosure Of Temporary Difference Unused Tax Losses And Unused Tax Credits [Line Items]
Disclosure Of Temporary Difference Unused Tax Losses And Unused Tax Credits [Line Items]
Deferred tax assets net
Deferred Tax Liability Asset
Recognized in P&L
Deferred Tax Expense Income Recognised In Profit Or Loss
Deferred tax assets net
Accumulated tax losses in corporate tax.
Accumulated tax losses in trade tax.
Corporate Tax
Accumulated Tax Losses In Corporate Tax
Trade Tax
Accumulated Tax Losses In Trade Tax
Deferred tax assets for unused tax losses recognized.
Deferred tax assets for unused tax losses recognized
Deferred Tax Assets For Unused Tax Losses Recognized
Shares issued during period stock split.
Shares issued during period stock split
Shares Issued During Period Stock Split
Loss attributable to ordinary equity holders of the parent for basic earnings
Weighted average number of ordinary shares for basic EPS
Weighted Average Shares
Effects of dilution from share options
Dilutive Effect Of Share Options On Number Of Ordinary Shares
Weighted average number of ordinary shares adjusted for the effect of dilution
Adjusted Weighted Average Shares
Reclassifications property plant and equipment.
Land and Buildings
Land And Buildings [Member]
Construction in progress and advance payments.
Construction in Progress and Advance Payments
Construction In Progress And Advance Payments [Member]
Cumulative Depreciation and Impairment Charges
Accumulated Depreciation Amortisation And Impairment [Member]
Property plant and equipment, Beginning balance
Additions
Additions Other Than Through Business Combinations Property Plant And Equipment
Depreciation
Depreciation Property Plant And Equipment
Disposals
Disposals Property Plant And Equipment
Reclassifications
Reclassifications Property Plant And Equipment
Currency differences
Increase Decrease Through Net Exchange Differences Property Plant And Equipment
Acquisition of subsidiaries and businesses, net of cash acquired
Acquisitions Through Business Combinations Property Plant And Equipment
Property plant and equipment, Ending balance
Accumulated depreciation amortisation and impairment.
Classes of intangible assets and goodwill [axis]
Classes Of Intangible Assets And Goodwill [Axis]
Intangible assets and goodwill [member]
Intangible Assets And Goodwill [Member]
Goodwill
Goodwill [Member]
Concessions, licenses and similar rights.
Concessions, Licenses and Similar Rights
Concessions Licenses And Similar Rights [Member]
Advance payments.
Advance Payments
Advance Payments [Member]
Beginning Balance
Amortization
Accumulated Depreciation Amortisation And Impairment
Additions
Additions Other Than Through Business Combinations Intangible Assets Other Than Goodwill
Disposals
Disposals Intangible Assets Other Than Goodwill
Reclassifications
Increase Decrease Through Transfers And Other Changes Intangible Assets Other Than Goodwill
Currency differences
Increase Decrease Through Net Exchange Differences Intangible Assets And Goodwill
Acquisition of subsidiaries and businesses, net of cash acquired
Acquisitions Through Business Combinations Intangible Assets Other Than Goodwill
Ending Balance
Contractual commitments
Contractual Commitments For Acquisition Of Intangible Assets
Consolidated structured entities [axis]
Consolidated Structured Entities [Axis]
Entity's total for consolidated structured entities [member]
Entitys Total For Consolidated Structured Entities [Member]
MAB Discovery.
MAB Discovery
M A B Discovery [Member]
JPT Peptide Technologies.
JPT Peptide Technologies
J P T Peptide Technologies [Member]
ReBOOST.
reBOOST
Re B O O S T [Member]
Goodwill
Goodwill
Pre-tax discount rate
Description Of Discount Rates Applied To Cash Flow Projections
Cash flows beyond the five-year period growth rate
Description Of Discount Rates Used In Current Estimate Of Value In Use
Cash And Cash Equivalents [Abstract]
Total
Disclosure Of Financial Assets [Abstract]
Disclosure Of Financial Assets [Table]
Disclosure Of Financial Assets [Table]
Classes of financial assets [axis]
Classes Of Financial Assets [Axis]
Financial assets, class [member]
Financial Assets [Member]
Trade Receivables
Trade Receivables [Member]
Other financial assets and receivables.
Other Financial Assets and Receivables
Other Financial Assets And Receivables [Member]
Disclosure Of Financial Assets [Line Items]
Disclosure Of Financial Assets [Line Items]
Financial assets at amortized cost
Financial Assets At Amortised Cost
Total current
Current Financial Assets At Amortised Cost
Total non-current
Noncurrent Financial Assets At Amortised Cost
Disclosure Of Financial Liabilities [Abstract]
Disclosure Of Financial Liabilities [Table]
Disclosure Of Financial Liabilities [Table]
Borrowings by name [axis]
Borrowings By Name [Axis]
Borrowings by name [member]
Borrowings By Name [Member]
Two point one five percentage secured bank loan.
2.15% Secured Bank loan
Two Point One Five Percentage Secured Bank Loan [Member]
Two point zero eight percentage secured bank loan.
2.08% Secured Bank loan
Two Point Zero Eight Percentage Secured Bank Loan [Member]
Liabilities arising from financing activities [axis]
Liabilities Arising From Financing Activities [Axis]
Liabilities arising from financing activities [member]
Liabilities Arising From Financing Activities [Member]
Trade payables.
Trade Payables
Trade Payables [Member]
Lease Liabilities
Lease Liabilities [Member]
Other financial liabilities.
Other Financial Liabilities
Other Financial Liabilities [Member]
Disclosure Of Financial Liabilities [Line Items]
Disclosure Of Financial Liabilities [Line Items]
Financial liabilities at amortized cost
Financial Liabilities At Amortised Cost
Total current
Current Financial Liabilities At Amortised Cost
Total non-current
Noncurrent Financial Liabilities At Amortised Cost
Financial liabilities maturity date.
Secured bank loan maturity date
Financial Liabilities Maturity Date
Secured bank loan
Financial Assets Pledged As Collateral For Liabilities Or Contingent Liabilities
Loan repayable quarterly installment.
Disclosure Of Redesignated Financial Assets And Liabilities [Abstract]
Disclosure Of Redesignated Financial Assets And Liabilities [Table]
Disclosure Of Redesignated Financial Assets And Liabilities [Table]
2.15% secured loan.
2.15% Secured Loan
Two Point One Five Percentage Secured Loan [Member]
2.08% bank loan.
2.08% Bank Loan
Two Point Zero Eight Percentage Bank Loan [Member]
Disclosure Of Redesignated Financial Assets And Liabilities [Line Items]
Disclosure Of Redesignated Financial Assets And Liabilities [Line Items]
Loan secured by land and buildings
Noncash Assets Pledged As Collateral For Which Transferee Has Right By Contract Or Custom To Sell Or Repledge Collateral
Loan secured by permanent guarantee
Loan repayable quarterly Installment
Loan Repayable Quarterly Installment
Undrawn available amount
Undrawn Borrowing Facilities
The amount of cash on hand and demand deposits denominated in foreign currencies.
Disclosure of cash and cash equivalents.
Disclosure of cash and cash equivalents.
Disclosure Of Cash And Cash Equivalents [Table]
Disclosure Of Cash And Cash Equivalents [Table]
Types of risks [axis]
Types Of Risks [Axis]
Risks [member]
Types Of Risks [Member]
Currency Risk
Currency Risk [Member]
USD Bank accounts.
USD Bank Accounts
U S D Bank Accounts [Member]
Disclosure Of Cash And Cash Equivalents [Line Items]
Disclosure Of Cash And Cash Equivalents [Line Items]
Total
Cash And Cash Equivalent
Disclosure of effect of changes in foreign exchange rates.
Disclosure Of Effect Of Changes In Foreign Exchange Rates [Abstract]
Disclosure of effect of changes in foreign exchange rates.
Disclosure of effect of changes in foreign exchange rates table.
Disclosure Of Effect Of Changes In Foreign Exchange Rates [Table]
Disclosure Of Effect Of Changes In Foreign Exchange Rates [Table]
Geographical areas [axis]
Geographical Areas [Axis]
Geographical areas [member]
Geographical Areas [Member]
United States
UNITED STATES
Currency
Currency [Axis]
All Currencies
All Currencies [Domain]
USD
U S D
Hedging instruments [axis]
Hedging Instruments [Axis]
Hedging instruments [member]
Hedging Instruments [Member]
Positive five percentage change in foreign exchange rate.
+5 %
Positive Five Percentage Change In Foreign Exchange Rate [Member]
Negative five percentage change in foreign exchange rate.
-5%
Negative Five Percentage Change In Foreign Exchange Rate [Member]
Disclosure Of Effect Of Changes In Foreign Exchange Rates [Line Items]
Disclosure Of Effect Of Changes In Foreign Exchange Rates [Line Items]
Closing rate
Closing Foreign Exchange Rate
Average rate
Average Foreign Exchange Rate
Foreign currency changes effect on loss before tax.
Foreign currency changes effect on pretax equity.
Effect on loss before tax
Foreign Currency Changes Effect On Loss Before Tax
Effect on pre-tax equity
Foreign Currency Changes Effect On Pretax Equity
1 to 5 Years
Later Than Two Years And Not Later Than Five Years [Member]
More than 5 years
Later Than Five Years [Member]
Liquidity Risk
Liquidity Risk [Member]
Interest bearing loans and borrowings
Interest Bearing Loans And Borrowings
Trade and other payables
Trade And Other Payables
Lease liabilities
Lease Liabilities
Other financial liabilities
Other Financial Liabilities
Total
Financial Liabilities
Disclosure Of Reconciliation Of Liabilities Arising From Financing Activities [Abstract]
Disclosure Of Reconciliation Of Liabilities Arising From Financing Activities [Table]
Disclosure Of Reconciliation Of Liabilities Arising From Financing Activities [Table]
Current obligations under lease contracts.
Current Obligations under Lease Contracts
Current Obligations Under Lease Contracts [Member]
Noncurrent obligations under lease contracts.
Non-current Obligations under Lease Contracts
Noncurrent Obligations Under Lease Contracts [Member]
Interest bearing loans and borrowings.
Interest-bearing Loans and Borrowings
Interest Bearing Loans And Borrowings [Member]
Disclosure Of Reconciliation Of Liabilities Arising From Financing Activities [Line Items]
Disclosure Of Reconciliation Of Liabilities Arising From Financing Activities [Line Items]
Beginning balance
Liabilities Arising From Financing Activities
Cash flows
Increase Decrease Through Financing Cash Flows Liabilities Arising From Financing Activities
New leases and disposals
Increase Through New Leases Liabilities Arising From Financing Activities
Reclassification
Increase Decrease Through Other Changes Liabilities Arising From Financing Activities
Ending balance
Raw materials and supplies
Current Raw Materials And Current Production Supplies
Unfinished goods
Work In Progress
Finished goods
Finished Goods
Total
Inventories recognized as an expense and recognized in cost of sales
Cost Of Inventories Recognised As Expense During Period
Trade and other receivables.
Trade and other receivables.
Trade And Other Receivables [Table]
Trade And Other Receivables [Table]
Trade And Other Receivables [Line Items]
Trade And Other Receivables [Line Items]
Other current assets other.
Sales tax receivable
Current Receivables From Taxes Other Than Income Tax
Prepayments on inventories
Current Prepayments
Other
Other Current Assets Other
Total
Receivables from interest.
Receivables from withholding taxes.
Interest income
Receivables From Interest
Receivables from withholding taxes
Receivables From Withholding Taxes
Disclosure Of Classes Of Share Capital [Table]
Disclosure Of Classes Of Share Capital [Table]
Associates [axis]
Significant Investments In Associates [Axis]
Entity's total for associates [member]
Entitys Total For Associates [Member]
Bill & Me linda Gates Foundation.
Bill & Melinda Gates Foundation
Bill And Me Linda Gates Foundation [Member]
Ordinary shares series B.
Ordinary Shares Series B
Ordinary Shares Series B [Member]
HONG KONG
HONG KONG
Capital requirements [axis]
Capital Requirements [Axis]
Capital requirements [member]
Capital Requirements [Member]
Initial public offering.
Initial Public Offering (IPO)
Initial Public Offering [Member]
Series A financing round.
Series A Financing Round
Series A Financing Round [Member]
Settling share-based payment plan.
Settling Share-based Payment Plan
Settling Share Based Payment Plan [Member]
Disclosure Of Classes Of Share Capital [Line Items]
Disclosure Of Classes Of Share Capital [Line Items]
Cash investment.
Shares issued
Number Of Shares Issued
Cash investment
Cash Investment
Ordinary shares issued
Number Of Shares Issued And Fully Paid
Aggregate proceeds from issuance of ordinary share
Proceeds From Issue Of Ordinary Shares
Shares issued price per share 1.
Increase in capital reserve.
Ordinary shares issued but not fully paid
Number Of Shares Issued But Not Fully Paid
Ordinary shares issued price per share
Shares Issued Price Per Share1
Increase in capital reserve
Increase In Capital Reserve
Recognition of treasury share balance
Increase Decrease Through Treasury Share Transactions
Increase in share capital
Changes In Equity
Acquisition of non-controlling interest.
Derecognition of non controlling interest.
Decrease in capital reserve.
Remaining non-controlling interests acquired
Remaining Noncontrolling Interests Acquired Percentage
Nominal value
Par Value Per Share
Derecognition of non-controlling interest
Derecognition Of Non Controlling Interest
Decrease in capital reserve
Decrease In Capital Reserve
Increase in issued capital.
Increase in issued capital
Increase In Issued Capital
Ordinary Shares
Ordinary Shares [Member]
Exercise price currency translation of public offering price per share.
Option vesting period.
Input parameter for performance criterion 1 - Threshold Amount.
Input parameter capitalization for performance criterion 2 - Target Price.
Input parameter increase factor for performance criterion 2 - Target Price.
The option rights can be exercised at the latest eight years after the allocation date. If they have not been exercised by that date, they will forfeit without compensation.
Option to purchase ordinary shares
Number Of Instruments Granted In Sharebased Payment Arrangement
Exercise price in translation for IPO
Exercise Price Currency Translation Of Public Offering Price Per Share
Option rights vesting term
Description Of Vesting Requirements For Sharebased Payment Arrangement
Option rights vesting period
Option Vesting Period
Percentage of exercise price increase
Percentage Of Increase In Exercise Price
Threshold amount of dividend by number of shares outstanding immediately following initial public offering
Threshold Amount Of Dividend By Number Of Shares Outstanding Immediately Following Initial Public Offering
Percentage of target share price applicable for prior twelve month period
Percentage Of Target Share Price Applicable For Prior Twelve Month
Option rights exercisable period
Option Exercisable Period
Weighted average fair value
Weighted Average Fair Value At Measurement Date Share Options Granted
Weighted average share price
Weighted Average Share Price Share Options Granted2019
Exercise price
Exercise Price Share Options Granted2019
Expected volatility (%)
Description Of Expected Volatility Share Options Granted
Expected life (years)
Description Of Option Life Share Options Granted
Risk-free interest rate (%)
Description Of Risk Free Interest Rate Share Options Granted
Beginning Balance, Share options
Number Of Outstanding Share Options
Granted, share options
Number Of Share Options Granted In Sharebased Payment Arrangement
Forfeited, share options
Number Of Share Options Forfeited In Sharebased Payment Arrangement
Ending Balance, Share options
Beginning Balance, Weighted-average exercise price
Weighted Average Exercise Price Of Share Options Outstanding In Sharebased Payment Arrangement2019
Granted, Weighted-average exercise price
Weighted Average Exercise Price Of Share Options Granted In Sharebased Payment Arrangement2019
Forfeited, Weighted-average exercise price
Weighted Average Exercise Price Of Share Options Forfeited In Sharebased Payment Arrangement2019
Ending Balance, Weighted-average exercise price
Options outstanding, weighted-average expected life
Weighted Average Remaining Contractual Life Of Outstanding Share Options2019
Expense From Sharebased Payment Transactions In Which Goods Or Services Received Did Not Qualify For Recognition As Assets [Abstract]
Nature of expenses.
Nature Of Expenses
Nature Of Expenses [Axis]
Nature of expenses.
Nature Of Expenses Member
Nature Of Expenses [Member]
Research and development expenses.
Research and Development Expenses
Research And Development Expenses [Member]
Cost of sales1.
Cost of Sales
Cost Of Sales1 [Member]
Sales and marketing expenses.
Sales and Marketing Expenses
Sales And Marketing Expenses [Member]
General and administrative expenses.
General and Administrative Expenses
General And Administrative Expenses [Member]
Share Appreciation Rights
Stock Appreciation Rights S A R S [Member]
Expense recognized for employee services received
Expense From Sharebased Payment Transactions With Employees
Number of share options cancelled or modified in share based payment arrangement
Cancellations or modifications to awards
Number Of Share Options Cancelled Or Modified In Sharebased Payment Arrangement
Number of ordinary shares underlying options outstanding.
Number of ordinary shares underlying options granted in sharebased payment arrangement.
Number of ordinary shares underlying options forfeited in sharebased payment arrangement.
Beginning Balance, Number of Ordinary Shares underlying options
Number Of Ordinary Shares Underlying Options Outstanding
Granted, Shares underlying options
Number Of Ordinary Shares Underlying Options Granted In Sharebased Payment Arrangement
Forfeited, Shares underlying options
Number Of Ordinary Shares Underlying Options Forfeited In Sharebased Payment Arrangement
Ending Balance, Number of Ordinary Shares underlying options
Granted options
Grant date
Date Of Grant Of Sharebased Payment Arrangement
Weighted average cost of capital as percentage share options granted.
Tax rate share options granted.
Debt free net working capital share options granted.
Long term growth rate share options granted
WACC
Weighted Average Cost Of Capital As Percentage Share Options Granted
Tax rate
Tax Rate Share Options Granted
Debt free net working capital (in % of sales)
Debt Free Net Working Capital Share Options Granted
Long-term growth rate (%)
Longterm Growth Rate Share Options Granted
Payments related to withholding tax for sharebased payment transactions.
Payments related to withholding tax for share-based payment transactions
Payments Related To Withholding Tax For Sharebased Payment Transactions
Current liabilities for employees benefits.
Other liabilities other.
Liabilities employees
Current Liabilities For Employees Benefits
Other
Other Liabilities Other
Total
Accruals for outstanding invoices
Accruals Classified As Current
Disclosure Of Quantitative Information About Rightofuse Assets [Abstract]
Additions to right-of-use assets
Additions To Rightofuse Assets
Lease liabilities
Lease Liabilities [Abstract]
Current
Current Lease Liabilities
Non-current
Noncurrent Lease Liabilities
Total
Lease expenses recognized in profit or loss.
Depreciation charge
Depreciation Rightofuse Assets
Interest on lease liabilities
Expense related to short-term leases (included in other expenses)
Expense Relating To Shortterm Leases For Which Recognition Exemption Has Been Used
Expense relating to leases of low-value assets that are not short-term leases (included in other expenses)
Expense Relating To Leases Of Lowvalue Assets For Which Recognition Exemption Has Been Used
Total amounts recognized in profit or loss
Lease Expenses Recognized In Profit Or Loss
Total cash outflow for leases
Cash Outflow For Leases
Number of business units.
Number of operation segments.
Number of operating segments in accordance with IFRS8.
Disclosure Of Operating Segments [Table]
Disclosure Of Operating Segments [Table]
Business unit BioNTech.
Business Unit BioNTech
Business Unit Biontech [Member]
Retrospective application and retrospective restatement [axis]
Retrospective Application And Retrospective Restatement [Axis]
Currently stated [member]
Restated [Member]
Adjustments.
Adjustments
Adjustments [Member]
Types of contracts [axis]
Types Of Contracts [Axis]
Types of contracts [member]
Types Of Contracts [Member]
Disclosure Of Operating Segments [Line Items]
Disclosure Of Operating Segments [Line Items]
Number of business units
Number Of Business Units
Number of operation segments
Number Of Operation Segments
Number of operating segments in accordance with IFRS 8
Number Of Operating Segments In Accordance With I F R S8
Clinical business unit.
Clinical
Clinical Business Unit [Member]
Technology platform business unit.
Technology Platform
Technology Platform Business Unit [Member]
Manufacturing business unit.
Manufacturing
Manufacturing Business Unit [Member]
Business service business unit.
Business Service
Business Service Business Unit [Member]
Product sales and external services business unit.
Product Sales &External Services
Product Sales And External Services Business Unit [Member]
Reportable Segments
Reportable Segments [Member]
Collaboration and license agreements.
Collaboration Revenues
Collaboration And License Agreements [Member]
Revenues
Revenue [Abstract]
Gross profit
Income / Expenses
Material Income And Expense [Abstract]
Other result
Other Operating Income Expense
Percentage of overall revenue
Percentage Of Entitys Revenue
Disclosure Of Transactions Between Related Parties [Table]
Disclosure Of Transactions Between Related Parties [Table]
Cofounder and chief executive officer.
Co-founder and Chief Executive Officer
Cofounder And Chief Executive Officer [Member]
Disclosure Of Transactions Between Related Parties [Line Items]
Disclosure Of Transactions Between Related Parties [Line Items]
Short-term employee benefits
Key Management Personnel Compensation Shortterm Employee Benefits
Share-based payment transactions
Key Management Personnel Compensation Sharebased Payment
Total compensation paid to key management personnel
Key Management Personnel Compensation
Consulting services and patent assignment.
Purchases of goods and service related party transactions.
Goods and services from related party transactions.
Key Management Personnel of Entity or Parent
Key Management Personnel Of Entity Or Parent [Member]
Consulting services / patent assignment
Consulting Services And Patent Assignment
Purchases of various goods and services from TRON
Purchases Of Goods And Service Related Party Transactions
Total
Goods And Services From Related Party Transactions
TRON.
TRON
T R O N [Member]
Outstanding balances
Amounts Payable Related Party Transactions
Purchases from related party transactions.
Other Related Parties
Other Related Parties [Member]
Purchases of various goods and services from entities controlled by ATHOS KG
Purchases of property and other assets from entities controlled by ATHOS KG
Purchases Of Property And Other Assets Related Party Transactions
Total
Purchases From Related Party Transactions
Outstanding balances of related party transaction
Provisions For Doubtful Debts Related To Outstanding Balances Of Related Party Transaction
Bad debt expense has been recognized
Expense Recognised During Period For Bad And Doubtful Debts For Related Party Transaction
Disclosure of events after reporting period.
Disclosure of events after reporting period.
Disclosure Of Events After Reporting Period [Table]
Disclosure Of Events After Reporting Period [Table]
Legal Entity
Legal Entity [Axis]
Entity
Entity [Domain]
Bio N Tech delivery technologies.
BioNTech Delivery Technologies
Bio N Tech Delivery Technologies [Member]
Lipo calyx.
Lipocalyx
Lipo Calyx [Member]
Non-adjusting events after reporting period [axis]
Nonadjusting Events After Reporting Period [Axis]
Non-adjusting events after reporting period [member]
Nonadjusting Events [Member]
Major Business Combination
Major Business Combination [Member]
Neon Therapeutics Inc.
Neon Therapeutics, Inc.
Neon Therapeutics Inc [Member]
Research and development effort.
R & D Effort
Research And Development Effort [Member]
Counterparties [axis]
Counterparties [Axis]
Counterparties [member]
Counterparties [Member]
Fosun Pharma.
Fosun Pharma
Fosun Pharma [Member]
Disclosure Of Events After Reporting Period [Line Items]
Disclosure Of Events After Reporting Period [Line Items]
Additional contingent consideration
Contingent Consideration Recognised As Of Acquisition Date
Current assets recognised as of acquisition date
Current Assets Recognised As Of Acquisition Date
Non-current assets recognised as of acquisition date
Noncurrent Assets Recognised As Of Acquisition Date
Liabilities recognised as of acquisition date
Financial Liabilities Recognised As Of Acquisition Date
American depository shares received upon conversion.
Stock transaction valued amount.
Closing price of American Depository Shares.
ADS received upon conversion
American Depository Shares Received Upon Conversion
Stock transaction valued amount
Stock Transaction Valued Amount
ADS closing price
Closing Price Of American Depository Shares
Upfront potential future investment and milestone payments.
Upfront potential future investment and milestone payments
Upfront Potential Future Investment And Milestone Payments
Equity investment
Investment Accounted For Using Equity Method
Number of shares issued